Table: begin end state 1 35 cytoplasmic 36 59 transmembrane 60 75 non-cytoplasmic 76 95 transmembrane 96 114 cytoplasmic 115 135 transmembrane 136 163 non-cytoplasmic 164 184 transmembrane 185 195 cytoplasmic 196 216 transmembrane 217 223 non-cytoplasmic 224 243 transmembrane 244 251 cytoplasmic 252 276 transmembrane 277 295 non-cytoplasmic 296 318 transmembrane 319 345 cytoplasmic 346 369 transmembrane 370 420 non-cytoplasmic 421 442 transmembrane 443 466 cytoplasmic 467 486 transmembrane 487 491 non-cytoplasmic 492 510 transmembrane 511 520 cytoplasmic 521 545 transmembrane 546 553 non-cytoplasmic 554 577 transmembrane 578 583 cytoplasmic 584 602 transmembrane 603 608 non-cytoplasmic 609 632 transmembrane 633 643 cytoplasmic 644 663 transmembrane 664 674 non-cytoplasmic 675 698 transmembrane 699 707 cytoplasmic 708 737 transmembrane 738 756 non-cytoplasmic
Input: >WP_085636380.1 NCBI__GCF_002115805.1:WP_085636380.1 MVQESTQADEGLIAEGVDEEPIEGNRRLFTGWRLQAVAGFAALYALFHMAALNGVSISAY TGITIPFLPQFPMETWNFRIVHIAGALALGFLVYNAMMFGDSDDEAGRSGPWDKIAYLLM LPALFALGTSLWFARTIASGELPEMGGLTTWPAFAGTPIYGQEVWYFGVPLLAASIGGVV LGWLEKAPRDQFRASDILLAICGVAVAAYLIAIYGTAARNSVGTPFVPIGVAFAATAGTV MILELTRRVAGLALVIITGVFLVYTFTAHLLPGILAVQSAYSWQRFFGHVYSDAGILGPT TAVSSTYIILFIIFAAFLQASKVGDYFVNFAFAAAGRARGGPAKVAIFASGLMGMINGTS AGNVVATGSLTIPLMKKVGYRPKVAGAVEAAASTGGQIMPPIMGAGAFIMAEITGIPYQD IAIAAIIPAVLYFVSVYFMVDFEAAKLGMRGMREDELPKLAKMVRQLYLFIPIIILIAAL FMGYSVIRAGTLATIAAAMVSWLTPFPMTLRGIAKAFELAGIMSIQIIAVCACAGIIVGV ISLTGVGARFSAVLLDLAATSQLLALFFAMCIAILLGMGMPTTAAYAVAASVVAPGLVQL GIPQLTAHFFVFYFAVLSAITPPVALASYAAAGISGANPMETSVVSFKVGIAAFIVPFMF FYNSALLMDGTWFEVIRAGVTAVFGVFLLSGGVQGWFLGQRSAWFIRLALIGAALFMIEG GLVTDLIGIGVTGAAWLVQKLFHPDPNAPIPVRGAD
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server